HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


EMA Revamp Could Be Hampered By Tight Budget And Staffing

This article was originally published in The Tan Sheet

Executive Summary

The European Medicines Agency plans a major restructuring plan to better aid its stakeholders, including firms considering OTC switch proposals or introducing other new OTCs, but tight staffing levels and budget stagnation could hamper the effort.

You may also be interested in...

European Regulatory Round Up: While EMA Opens Up, European Pharma Battens Down For Tough Year

The European Medicines Agency is focusing on transparency and pharmacovigilance over the next year, while the pharmaceutical industry is gearing up for a fight against austerity measures.

People In Brief

DuPont elbows out Danisco execs

Mediator Is Tip Of EU Parliament's Probe Into EMA; Funding Held In Balance

The European Parliament blocks approval of EMA's budget accounts, citing handling of Mediator and broader conflict of interest concerns.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts